Form 8.3 - Udg Healthcare Plc
17 Agosto 2021 - 4:33PM
UK Regulatory
TIDMUDG
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
------------------------------------ ------------------------------
Company dealt in UDG Healthcare plc
------------------------------------ ------------------------------
Class of relevant security to EUR0.05 ordinary shares
which
the dealings being disclosed relate
(Note 2)
------------------------------------ ------------------------------
Date of dealing 16th August 2021
------------------------------------ ------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
--------------------------- ---------------- -----------
Number (%) Number (%)
--------------------------- ------ -------- ------ ---
(1) Relevant securities 0 0.00000%
--------------------------- ------ -------- ------ ---
(2) Derivatives (other
than options) N/A
--------------------------- ------ -------- ------ ---
(3) Options and agreements
to
purchase/sell N/A
--------------------------- ------ -------- ------ ---
Total 0 0.00000%
--------------------------- ------ -------- ------ ---
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
--------------------------- ----------- -----------
Number (%) Number (%)
--------------------------- ------ --- ------ ---
(1) Relevant securities N/A
--------------------------- ------ --- ------ ---
(2) Derivatives (other N/A
than options)
--------------------------- ------ --- ------ ---
(3) Options and agreements N/A
to purchase/sell
--------------------------- ------ --- ------ ---
Total N/A
--------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note
5)
------------- ----------------------------- --------------------
Transfer Out 2,766,063 N/A
------------- ----------------------------- --------------------
(b) Derivatives transactions (other than options
transactions)
Product name, Nature of transaction Number of relevant securities Price per
e.g. CFD (Note 6) (Note 7) unit
(Note 5)
------------- --------------------- ----------------------------- ---------
N/A
------------- --------------------- ----------------------------- ---------
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call selling, securities to price American, date paid/received
option purchasing which European per unit
varying etc. the option relates etc. (Note 5)
(Note 7)
------------- ------------- ------------------- -------- ---------- ------ --------------
N/A
------------- ------------- ------------------- -------- ---------- ------ --------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note
5)
--------------------- ------- ----------------------
N/A
--------------------- ------- ----------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding between
the person disclosing and any other person relating to the voting
rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be
stated.
--------------------------------------------------------------------
N/A
--------------------------------------------------------------------
Is a Supplemental Form 8 attached?
(Note 9) NO
-------------------------------------------- ----------------
Date of disclosure 17th August 2021
-------------------------------------------- ----------------
Contact name Lionel Colaco
-------------------------------------------- ----------------
Telephone number 020 33956098
-------------------------------------------- ----------------
If a connected EFM, name of offeree/offeror N/A
with which connected
-------------------------------------------- ----------------
If a connected EFM, state nature N/A
of connection (Note 10)
-------------------------------------------- ----------------
(END) Dow Jones Newswires
August 17, 2021 10:33 ET (14:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Udg Healthcare Public (LSE:UDG)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Udg Healthcare Public (LSE:UDG)
Storico
Da Giu 2023 a Giu 2024